Page last updated: 2024-08-16

opc 12759 and oxazolone

opc 12759 has been researched along with oxazolone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, P; Li, R; Li, W; Liang, K; Ma, W; Wang, Y; Xu, X; Zhao, Y	1

Other Studies

1 other study(ies) available for opc 12759 and oxazolone

Article	Year
Rebamipide suppresses TNF-α mediated inflammation in vitro and attenuates the severity of dermatitis in mice. The FEBS journal, 2015, Volume: 282, Issue:12 Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Transformed; Dermatitis, Allergic Contact; Disease Models, Animal; Gene Expression Regulation; Genes, Reporter; Inflammation Mediators; Lymph Nodes; Macrophage Activation; Macrophages; Male; Mice, Inbred C57BL; NF-kappa B; Oxazolone; Quinolones; Severity of Illness Index; Signal Transduction; Skin; Tumor Necrosis Factor-alpha	2015

Article

Year

Rebamipide suppresses TNF-α mediated inflammation in vitro and attenuates the severity of dermatitis in mice.

The FEBS journal, 2015, Volume: 282, Issue:12

Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Transformed; Dermatitis, Allergic Contact; Disease Models, Animal; Gene Expression Regulation; Genes, Reporter; Inflammation Mediators; Lymph Nodes; Macrophage Activation; Macrophages; Male; Mice, Inbred C57BL; NF-kappa B; Oxazolone; Quinolones; Severity of Illness Index; Signal Transduction; Skin; Tumor Necrosis Factor-alpha

2015